Advertisement

Topics

EFFECTOR to team up with Merck, Pfizer on cancer combo drug study

05:54 EDT 21 Jun 2017 | SmartBrief

EFFECTOR Therapeutics will initiate a midstage trial to evaluate its eFT508 in combination with Merck KGaA's and Pfizer's Bav -More

Original Article: EFFECTOR to team up with Merck, Pfizer on cancer combo drug study

NEXT ARTICLE

More From BioPortfolio on "EFFECTOR to team up with Merck, Pfizer on cancer combo drug study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...